Article

Combination system provides extra protection

Nashville, TN—DuoVisc (Alcon Laboratories), a combination product that provides one unit of 0.35 ml Viscoat viscoelastic solution (3% sodium hyaluronate/chondroitin sulfate), a dispersive viscoelastic, and one unit of 0.40 ml ProVisc (1% sodium hyaluronate), a cohesive viscoelastic, allows surgeons to protect the endothelium, open spaces in the eye, and implant IOLs with ease.

Related Videos
2 experts are featured in this series.
Related Content
Ophthalmology Times 2024 wrap-up: A year of innovation and insight
December 26th 2024

Ophthalmology Times 2024 wrap-up: A year of innovation and insight

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease
December 26th 2024

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Published: December 26th 2024 | Updated: December 26th 2024

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies

Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
Published: December 26th 2024 | Updated: December 26th 2024

Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery

© 2024 MJH Life Sciences

All rights reserved.